Terai S - Search Results

1

Medaka as a model for human nonalcoholic steatohepatitis.

Matsumoto T, Terai S, Oishi T, Kuwashiro S, Fujisawa K, Yamamoto N, Fujita Y, Hamamoto Y, Furutani-Seiki M, Nishina H, Sakaida I. Matsumoto T, et al. Among authors: terai s. Dis Model Mech. 2010 Jul-Aug;3(7-8):431-40. doi: 10.1242/dmm.002311. Epub 2010 Apr 6. Dis Model Mech. 2010. PMID: 20371730 Free article.

2

Inhibition of tumor necrosis factor-alpha production retards liver regeneration after partial hepatectomy in rats.

Kimura T, Sakaida I, Terai S, Matsumura Y, Uchida K, Okita K. Kimura T, et al. Among authors: terai s. Biochem Biophys Res Commun. 1997 Feb 24;231(3):557-60. doi: 10.1006/bbrc.1997.6135. Biochem Biophys Res Commun. 1997. PMID: 9070844

3

Ubiquitin is a possible new predictive marker for the recurrence of human hepatocellular carcinoma.

Shirahashi H, Sakaida I, Terai S, Hironaka K, Kusano N, Okita K. Shirahashi H, et al. Among authors: terai s. Liver. 2002 Oct;22(5):413-8. doi: 10.1034/j.1600-0676.2002.01541.x. Liver. 2002. PMID: 12458564

4

A new cell therapy using bone marrow cells to repair damaged liver.

Terai S, Yamamoto N, Omori K, Sakaida I, Okita K. Terai S, et al. J Gastroenterol. 2002 Nov;37 Suppl 14:162-3. doi: 10.1007/BF03326438. J Gastroenterol. 2002. PMID: 12572886 Review.

5

Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet.

Sakaida I, Tsuchiya M, Kawaguchi K, Kimura T, Terai S, Okita K. Sakaida I, et al. Among authors: terai s. J Hepatol. 2003 Jun;38(6):762-9. doi: 10.1016/s0168-8278(03)00094-1. J Hepatol. 2003. PMID: 12763369

6

Leptin receptor-deficient Zucker (fa/fa) rat retards the development of pig serum-induced liver fibrosis with Kupffer cell dysfunction.

Sakaida I, Jinhua S, Uchida K, Terai S, Okita K. Sakaida I, et al. Among authors: terai s. Life Sci. 2003 Sep 26;73(19):2491-501. doi: 10.1016/s0024-3205(03)00653-2. Life Sci. 2003. PMID: 12954457

7

Arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and isovorin for patients with advanced hepatocellular carcinoma, pilot study: Is a high dose of the biochemical modulator effective?

Yamasaki T, Kurokawa F, Takami T, Omori K, Kawaguchi K, Tsuchiya M, Yamamoto N, Okamoto M, Hironaka K, Kimura T, Terai S, Sakaida I, Okita K. Yamasaki T, et al. Among authors: terai s. Hepatol Res. 2003 Sep;27(1):36-44. doi: 10.1016/s1386-6346(03)00195-5. Hepatol Res. 2003. PMID: 12957205

8

An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes.

Terai S, Sakaida I, Yamamoto N, Omori K, Watanabe T, Ohata S, Katada T, Miyamoto K, Shinoda K, Nishina H, Okita K. Terai S, et al. J Biochem. 2003 Oct;134(4):551-8. doi: 10.1093/jb/mvg173. J Biochem. 2003. PMID: 14607982 Free article.

9

A subpopulation of bone marrow cells depleted by a novel antibody, anti-Liv8, is useful for cell therapy to repair damaged liver.

Yamamoto N, Terai S, Ohata S, Watanabe T, Omori K, Shinoda K, Miyamoto K, Katada T, Sakaida I, Nishina H, Okita K. Yamamoto N, et al. Among authors: terai s. Biochem Biophys Res Commun. 2004 Jan 23;313(4):1110-8. doi: 10.1016/j.bbrc.2003.12.044. Biochem Biophys Res Commun. 2004. PMID: 14706657

10

Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell.

Sakaida I, Hironaka K, Kimura T, Terai S, Yamasaki T, Okita K. Sakaida I, et al. Among authors: terai s. Life Sci. 2004 Mar 19;74(18):2251-63. doi: 10.1016/j.lfs.2003.09.059. Life Sci. 2004. PMID: 14987950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

665 results

Search Page

Filters